Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04420585 · ClinicalTrials.gov registry record · Phase 4
Desmopressin for Bedwetting in Children With SCD
A Phase 4 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT04420585 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT04420585, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.
Interventions
- DRUG Desmopressin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2023-06-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04420585
The ClinicalTrials.gov registry entry for NCT04420585 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Desmopressin is the first listed.
NCT04420585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04420585 about?
NCT04420585 is a clinical study titled "Desmopressin for Bedwetting in Children With SCD". This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.
What is the current status of trial NCT04420585?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2020-07-07. Estimated completion is 2023-06-12.
What interventions are being tested in trial NCT04420585?
The interventions under investigation include: Desmopressin (DRUG).
Who is sponsoring clinical trial NCT04420585?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.